SMTI Sanara MedTech Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 714256 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.8%
TTM net income YoY92.0%
TTM EPS YoY91.9%
Revenue 3-yr CAGR21.4%
Net income 3-yr CAGR—
Margins
Gross margin93.0%
Operating margin5.6%
Net margin-2.7%
FCF margin6.5%
EBITDA margin7.8%
Returns
ROE-43.7%
ROA-4.2%
ROIC (approx.)13.3%
Asset turnover1.56x
Leverage & solvency
Liabilities / assets89.4%
Debt / equity6.10x
Current ratio2.24x
Interest coverage0.86x
Cash quality & payout
Operating cash flow / net income-2.46x
Accruals ratio-14.6%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $103.12M | $86.67M | $64.99M | $45.84M | $24.14M |
| Cost of revenue | $7.52M | $8.14M | $7.85M | $6.36M | $2.31M |
| Gross profit | $95.60M | $78.53M | $57.14M | $39.48M | $21.83M |
| R&D expense | $5.07M | $2.83M | $4.13M | $3.37M | $558,704 |
| SG&A expense | $78.72M | $71.67M | $56.99M | $45.98M | $28.05M |
| Operating income | $7.30M | $1.26M | -$4.22M | -$12.52M | -$7.38M |
| Interest expense | $6.76M | $3.13M | $475,783 | $284,746 | $711 |
| Pretax income | -$393,124 | -$1.89M | -$4.44M | -$13.94M | -$7.99M |
| Income tax | — | $48,380 | — | -$5.84M | — |
| Net income | -$37.56M | -$9.66M | -$4.30M | -$7.94M | -$7.92M |
| EBITDA | $11.25M | $6.18M | -$540,127 | -$10.15M | -$6.78M |
| EPS (basic) | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
| EPS (diluted) | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
| Weighted avg. shares (diluted) | 8.62M | 8.48M | 8.28M | 7.91M | 7.34M |
| Balance sheet | |||||
| Cash & equivalents | $16.58M | $15.88M | $5.15M | $8.96M | $18.65M |
| Receivables | $12.00M | — | — | $6.81M | $2.86M |
| Inventory | $3.95M | $2.75M | $4.72M | $3.55M | $2.05M |
| Current assets | $33.54M | $33.31M | $19.01M | $20.62M | $24.61M |
| PP&E, net | $456,962 | $432,317 | $1.26M | $1.42M | $1.63M |
| Goodwill | $3.60M | $3.60M | $3.60M | $3.60M | — |
| Intangibles | $18.64M | $23.48M | $44.93M | $31.51M | $4.73M |
| Total assets | $72.94M | $88.09M | $73.87M | $61.04M | $36.40M |
| Current liabilities | $18.63M | $15.29M | $13.77M | $12.81M | $6.02M |
| Short-term debt | — | — | $580,357 | — | — |
| Long-term debt | $45.97M | $30.69M | $9.11M | — | — |
| Total debt | $45.97M | $30.69M | $9.69M | — | — |
| Total liabilities | $67.01M | $49.18M | $29.28M | $19.32M | $6.24M |
| Shareholders' equity | $5.94M | $39.40M | $44.83M | $41.83M | $30.64M |
| Net debt | $29.39M | $14.81M | $4.55M | — | — |
| Shares outstanding | 8.95M | 8.75M | 8.54M | 8.30M | 7.68M |
| Cash flow statement | |||||
| Operating cash flow | $6.79M | -$23,784 | -$3.25M | -$5.55M | -$4.81M |
| Capital expenditure | $4.63M | $205,848 | $265,246 | $147,015 | $171,867 |
| Free cash flow | $2.16M | -$229,632 | -$3.51M | -$5.70M | -$4.99M |
| Investing cash flow | -$14.97M | -$6.61M | -$10.21M | -$3.51M | -$5.28M |
| Financing cash flow | $8.89M | $17.37M | $9.64M | -$627,346 | $28.30M |
| Depreciation & amortization | $3.95M | $4.92M | $3.68M | $2.37M | $596,975 |
| Stock-based compensation | $5.15M | $4.44M | $3.44M | $2.70M | $2.67M |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.